MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Pulmonology, Respiratory
Ventus Therapeutics
Organization & Developments: Ventus Therapeutics
Parents
Ventus Therapeutics
Children
*They use two platforms – Structural Immunology and ReSOLVE™ – to treat autoimmune diseases, inflammatory diseases and cancer.
*Ventus Therapeutics is a biopharmaceutical company discovering and developing novel small-molecule medicines by pioneering new frontiers in structure-based drug discovery for biologically validated, but elusive, drug targets.
2022: Novo enters NLRP3 arena, paying Ventus $70M for NASH hopeful
Jumps
Finance & Acquisitions: Ventus Therapeutics
Key People: Ventus Therapeutics